Loading...
Docoh

Koss (KOSS)

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement, and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins, and protein complexes.

Company profile

Ticker
KOSS
Exchange
Website
CEO
Michael J. Koss
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Koss U.K. Limited • Koss B.V. ...
IRS number
391168275

KOSS stock data

Calendar

5 May 22
12 Aug 22
30 Jun 23
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Jun 21 Jun 20 Jun 19 Jun 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 9.49M 9.49M 9.49M 9.49M 9.49M 9.49M
Cash burn (monthly) (no burn) (no burn) (no burn) (no burn) 97.39K (no burn)
Cash used (since last report) n/a n/a n/a n/a 428.96K n/a
Cash remaining n/a n/a n/a n/a 9.06M n/a
Runway (months of cash) n/a n/a n/a n/a 93.0 n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
2 Jun 22 William Jesse Sweasy Common Stock Buy Acquire P No No 7.3 2,847 20.78K 20,000
1 Jun 22 William Jesse Sweasy Common Stock Buy Acquire P No No 6.96 17,153 119.38K 17,153
23 Mar 22 Koss John C JR Common Stock Dispose Z Yes No 0 983,800 0 0
23 Mar 22 Koss John C JR Common Stock Dispose Z Yes No 0 707,949 0 0
23 Mar 22 Koss John C JR Common Stock Dispose Z Yes No 0 1,000,885 0 0
23 Mar 22 Koss Michael J Common Stock Acquire Z Yes No 0 2,696,634 0 2,696,634
23 Mar 22 Koss Michael J Common Stock Dispose Z Yes No 0 983,800 0 0
23 Mar 22 Koss Michael J Common Stock Dispose Z Yes No 0 707,949 0 0
23 Mar 22 Koss Michael J Common Stock Dispose Z Yes No 0 1,000,885 0 0
23 Mar 22 KFT Common Stock Dispose Z No No 0 983,800 0 0
10.9% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 1 25 -96.0%
Opened positions 0 6 EXIT
Closed positions 24 6 +300.0%
Increased positions 0 8 EXIT
Reduced positions 0 8 EXIT
13F shares Current Prev Q Change
Total value 35.03M 65.78M -46.7%
Total shares 1M 3.17M -68.5%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Koss Michael J Jr 1M $35.03M 0.0%
Koss Michael J 0 $0 EXIT
Largest transactions Shares Bought/sold Change
Koss Michael J 0 -1M EXIT
CIBC Private Wealth 0 -546.53K EXIT
Vanguard 0 -183.93K EXIT
Dimensional Fund Advisors 0 -154.55K EXIT
BLK Blackrock 0 -61.6K EXIT
Geode Capital Management 0 -52.85K EXIT
Cresset Asset Management 0 -40K EXIT
MS Morgan Stanley 0 -33.8K EXIT
Jane Street 0 -33.34K EXIT
STT State Street 0 -17.17K EXIT

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: added, blended, Chinese, conflict, declared, dedicated, disgorgement, distributor, driver, drop, dropped, ease, Eastern, environment, fewer, humanitarian, imposed, inflationary, invasion, largest, linger, minimal, minimize, moderate, Omicron, ongoing, Order, packaging, partner, persistence, political, receipt, refuge, repeat, resurgence, Russia, seeking, subvariant, suit, suspended, translated, transportation, trial, Ukraine, varied, Western, wholly
Removed: effect, experiencing, home, implement, online, routing, significantly, studying